Laurus Labs to invest Rs 83 crore in KRKA Pharma
Advertisement
Hyderabad: Laurus Labs has announced that the Company has approved an investment of Rs 83 crore in KRKA Pharma, a joint venture of the Company.
"We would like to inform you that the Board of Directors of the Company at their Meeting held on Thursday, 06th March, 2025, inter-alia, have approved for investment of an amount of INR 833,000,000/- (Indian Rupees Eight Hundred and Thirty Three Million only) in KRKA Pharma Private Limited, a joint venture of the Company.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.